Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...

A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...

Harvey Jones says investment brokers showed their love for AstraZeneca shares at the start of the year, but maybe wondering if that's been reciprocated. The post 21 analysts advised buy AstraZeneca ...

The company removed experimental drugs for Alzheimer’s, migraine and pain from its pipeline to focus more resources on “core ...

A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ ...

"Portugal is very attractive for staff and in terms of talent" - Nathalie von Widdern, country president, AstraZeneca.

AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ...

AstraZeneca’s Imfinzi is part of a comprehensive development programme, being evaluated both as a standalone and in conjunction with other therapies for various cancers. Credit: Michael ...

AstraZeneca’s Trixeo Aerosphere approved in UK as first inhaled respiratory medicine using next-generation propellant with near-zero GWP: Cambridge, UK Tuesday, May 13, 2025, 09 ...

As it applies to the development of cell therapies, AstraZeneca’s chief of global operations, Pam Cheng, admits that the ...

By Sandra Agyeiwaa OTOOTrust Specialists Hospital, in partnership with AstraZeneca, has marked World Asthma Day 2025 with a ...

AstraZeneca plans to submit the positive data Breztri Aerosphere in asthma for to regulatory authorities for review.